RecruitingEarly Phase 1NCT06416969

Regional Lipolysis and Adipocyte Lipolysis Protein Stimulation

Stimulation of Regional Lipolysis and Adipocyte Lipolysis Proteins

Sponsor

Mayo Clinic

Enrollment

24 participants

Start Date

Jan 1, 2024

Study Type

INTERVENTIONAL

Conditions

Obesity

Summary

Adults who gain most of their excess weight in the abdominal area typically do not respond to factors that "turn on" fat cells the same way as people who don't have excessive weight. Researchers are trying to understand why fat tissue responds differently in people with different body types.

Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Epinephrine and a drug called Somatostatin for people with obesity. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.